Hi Guest
Real-Time Quote
Enter Company or MFAstraZeneca Pharma India Ltd.
BSE | NSE
506820 ASTRAZEN Group (B) BSE data
Add to Watchlist
| View Tips
How hot is this stock? © Rediff.com
* Computed on last 15 days' trading figures.
Report card
| Attribute | Value | Date |
|---|---|---|
| PE ratio | -22.32 | 17/05/13 |
| EPS (Rs) | -35.81 | Mar, 13 |
| Sales (Rs crore) | 94.92 | Mar, 13 |
| Face Value (Rs) | 2 | |
| Net profit margin (%) | 3.68 | Mar, 12 |
| Last bonus | 1:1 | 04/10/95 |
| Last dividend (%) | 175 | 12/05/12 |
| Return on average equity | 10.44 | Mar, 12 |
Research centre
Results Statement More
MFs invested in this company
AnnouncementsMore 
| 16 May | Board to consider Dividend | |
| 06 May | Outcome of Board Meeting
 | |
| 03 May | Board Meeting on May 06, 2013 | |
| 02 May | Financial Results and Limited Review for March 31, 2013
| |
| 18 Apr | Publish Audited Results | |
| 05 Mar | Updates | |
| 06 Feb | Outcome of Board Meeting | |
| 06 Feb | Announces Q3 results and Limited Review Report for the Quarter ended December 31, 2012
| |
| 23 Jan | Q3 results on Feb 06, 2013 | |
| 27 Nov 2012 | Clarification | |
Compare with
Add Your Stock Call
Thank you. Your call will appear shortly. Your returns will be updated at the end of the trading day. View All CallsMutual Fund Selector
Find the fund that is right for youMarket Astrology
Stock market predictions by Satish GuptaAll MoneyWiz Pages
© Copyright 2012 Rediff.com India Limited. All rights reserved. DisclaimerTerms of ServicePrivacy PolicyFeedback